# Influenza Vaccine in HIV Study

> **NCT02632578** · — · COMPLETED · sponsor: **University of Melbourne** · enrollment: 57 (actual)

## Conditions studied

- Influenza, Human

## Interventions

- **BIOLOGICAL:** 2015 Fluvax® vaccine, BioCSL (a licensed influenza vaccine)

## Key facts

- **NCT ID:** NCT02632578
- **Lead sponsor:** University of Melbourne
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-02
- **Primary completion:** 2015-06
- **Final completion:** 2015-12
- **Target enrollment:** 57 (ACTUAL)
- **Last updated:** 2015-12-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02632578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02632578, "Influenza Vaccine in HIV Study". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT02632578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*